• Abraham SC, Kamath PS, Eghtesad B, Demetris AJ, Krasinskas AM 2006 Liver transplantation in precirrhotic biliary tract disease: portal hypertension is frequently associated with nodular regenerative hyperplasia and obliterative portal venopathy. Am. J. Surg. Pathol. 30: 1454-1461.

• Agarwal K, Jones DE, Watt FE, Burt AD, Floreani A, Bassendine MF 2002 Familial primary biliary cirrhosis and autoimmune cholangitis. Dig. Liver Dis. 34: 50-52.

• Agoston-Coldea L, Fodor D, Pais R, Rusu ML, Georgiu C 2002 Autoimmune cholangitis in patients with primary Sjogren's syndrome. A case report. Rom. J. Gastroenterol. 11: 321-324.

• Akisawa N, Nishimori I, Miyaji E, Iwasaki S, Maeda T, Shimizu H, Sato N, Onishi S 1999 The ability of anti-carbonic anhydrase II antibody to distinguish autoimmune cholangitis from primary biliary cirrhosis in Japanese patients. J. Gastroenterol. 34: 366-371.

• Angulo P, Lindor KD 1998 Management of primary biliary cirrhosis and autoimmune cholangitis. Clin. Liver Dis. 2: 333-351, ix.

• Archimandritis A, Tjivras M, Tsirantonaki M, Hatzis G, Delladetsima I 1995 Sjogren's syndrome with antimitochondrial antibody-negative primary biliary cirrhosis: a case of autoimmune cholangitis. J. Clin. Gastroenterol. 20: 268-270.

• Ballardini G, Mirakian R, Bianchi FB, Pisi E, Doniach D, Bottazzo GF 1984 Aberrant expression of HLA-DR antigens on bileduct epithelium in primary biliary cirrhosis: relevance to pathogenesis. Lancet 2: 1009-1013.

• Batts KP, Wang X 1998 Recurrence of primary biliary cirrhosis, autoimmune cholangitis and primary sclerosing cholangitis after liver transplantation. Clin. Liver Dis. 2: 421-435, xi.

• Berg PA, Klein R 2002 Autoimmune hepatitis and overlap syndrome: diagnosis. Schweiz. Rundsch. Med. Prax. 91: 1339-1346.

• Biecker E, Stieger M, Zimmermann A, Reichen J 2003 Autoimmune hepatitis, cryoglobulinaemia and untreated coeliac disease: a case report. Eur. J. Gastroenterol. Hepatol. 15: 423-427.

• Bogdanos D, Vergani D, Mieli-Vergani G 2004 Overlap syndromes from pediatrics to adulthood. J. Gastroenterol. Hepatol. 19: S284-S286. *

• Broome U 2003 Autoimmune hepatitis and overlap syndromes. Falk Symposium 135. Immmunological diseases of liver and gut. Prague (Czech Republic). p. 38-39. September 12 - 13. *

• Burt AD 2002 Primary biliary cirrhosis and other ductopenic diseases. Clin. Liver Dis. 6: 363-380.

• Burt AD 2004 Spectrum of liver pathology in immune mediated liver diseases. J. Gastroenterol. Hepatol. 19: S353-S355. *

• Caprai S, Vajro P, Ventura A, Sciveres M, Maggiore G; SIGENP study group for autoimmune liver disorders in celiac disease 2008 Autoimmune liver disease associated with celiac disease in childhood: a multicenter study. Clin. Gastroenterol. Hepatol. 6: 803-806.

• Carpenter HA, Czaja AJ 2002 The role of histologic evaluation in the diagnosis and management of autoimmune hepatitis and its variants. Clin. Liver Dis. 6: 397-417.

• Castellano Tortajada G, Sanchez Pobre P 2000 Autoimmune cholangitis. Gastroenterol. Hepatol. 23 Suppl. 1: 14-23.

• Chatzicostas C, Roussomoustakaki M, Drygiannakis D, Niniraki M, Tzardi M, Koulentaki M, Dimoulios P, Mouzas I, Kouroumalis E 2002 Primary biliary cirrhosis and autoimmune cholangitis are not associated with coeliac disease in Crete. BMC Gastroenterol. 2: 5. *

• Cho YJ, Han DS, Kim TY, Jang SJ, Jeon YC, Sohn JH, Lee IH, Park KN 1999 Negative conversion of antimitochondrial antibody in primary biliary cirrhosis: a case of autoimmune cholangitis. J. Korean Med. Sci. 14: 102-106.

• Cholongitas E, Pipili C, Dasenaki M, Kaklamanis L 2008 Piperacillin/tazobactam-induced Sweet syndrome in a patient with chronic lymphocytic leukemia and autoimmune cholangitis. Am. J. Dermatopathol. 30: 203-204.

• Colombato LA, Alvarez F, Cote J, Huet PM 1994 Autoimmune cholangiopathy: the result of consecutive primary biliary cirrhosis and autoimmune hepatitis? Gastroenterology 107: 1839-1843.

• Cornelis T, Hiele M, Vermeire S, Libbrecht L, Verslype C 2008 A unique combination of celiac disease, mesenteric lymph node cavitation, splenic atrophy and necrotizing hepatitis. Acta Gastroenterol. Belg. 71: 267-270.

• Czaja AJ 1999 Variant forms of autoimmune hepatitis. Curr. Gastroenterol. Rep. 1: 63-70.

• Czaja AJ 1996 The variant forms of autoimmune hepatitis. Ann. Intern. Med. 125: 588-598.

• Czaja AJ 2000 Autoimmune liver disease. Curr. Opin. Gastroenterol. 16: 262-270.

• Czaja AJ 2006 Autoimmune hepatitis - approach to diagnosis. MedGenMed. 8: 55.

• Czaja AJ 1998 Frequency and nature of the variant syndromes of autoimmune liver disease. Hepatology 28: 360-365. *

• Czaja AJ, Carpenter HA, Santrach PJ, Moore SB 2000 Autoimmune cholangitis within the spectrum of autoimmune liver disease. Hepatology 31: 1231-1238. *

• Dienes HP 2005 Autoimmune hepatitis and autoimmune cholangitis. Verh. Dtsch. Ges. Pathol. 89: 155-162.

• Dunn JM, McNair A 2007 Prolonged cholestasis following successful removal of common bile duct stones: beware patients on estrogen therapy. World J. Gastroenterol. 13: 6277-6280. *

• Gisbert JP, Jones EA, Pajares JM, Moreno-Otero R 2003 Review article: is there an optimal therapeutic regimen for antimitochondrial antibody-negative primary biliary cirrhosis (autoimmune cholangitis)? Aliment. Pharmacol. Ther. 17: 17-27. *

• Gogos CA, Nikolopoulou V, Zolota V, Siampi V, Vagenakis A 1999 Autoimmune cholangitis in a patient with celiac disease: a case report and review of the literature. J. Hepatol. 30: 321-324. *

• Goodman ZD, McNally PR, Davis DR, Ishak KG 1995 Autoimmune cholangitis: a variant of primary biliary cirrhosis. Clinicopathologic and serologic correlations in 200 cases. Dig. Dis. Sci. 40: 1232-1242.

• Gordon SC, Quattrociocchi-Longe TM, Khan BA, Kodali VP, Chen J, Silverman AL, Kiechle FL 1995 Antibodies to carbonic anhydrase in patients with immune cholangiopathies. Gastroenterology 108: 1802-1809. *

• Hama K, Miwa H, Nishino I, Nonaka I, Kondo T 2004 Inclusion body myositis associated with chronic thyroiditis, Sjogren's syndrome and autoimmune cholangitis. No To Shinkei 56: 503-507.

• Hasegawa Y, Ohi M, Fujisaku A 2000 Autoimmune cholangitis (AIC) associated with myositis in monozygotic twins. Ryumachi 40: 898-903.

• Heathcote EJ 1998 Autoimmune cholangitis. Clin. Liver Dis. 2: 303-311, viii-ix.

• Heathcote J 2003 Overlap syndromes - outlier syndromes and changing diagnoses. Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper’s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 39-41. October 15-16. *

• Hong-Curtis J, Yeh MM, Jain D, Lee JH 2004 Rapid progression of autoimmune hepatitis in the background of primary sclerosing cholangitis. J. Clin. Gastroenterol. 38: 906-909.

• Hosoda H, Okawa-Takatsuji M, Tanaka A, Uwatoko S, Aotsuka S, Hasimoto N, Ozaki Y, Ikeda Y 2004 Detection of autoantibody against carbonic anhydrase II in various liver diseases by enzyme-linked immunosorbent assay using appropriate conditions. Clin. Chim. Acta 342: 71-81. *

• Hurlburt KJ, McMahon BJ, Deubner H, Hsu-Trawinski B, Williams JL, Kowdley KV 2002 Prevalence of autoimmune liver disease in Alaska Natives. Am. J. Gastroenterol. 97: 2402-2407. *

• Ikuno N, Scealy M, Davies JM, Whittingham SF, Omagari K, Mackay IR, Rowley MJ 2001 A comparative study of antibody expressions in primary biliary cirrhosis and autoimmune cholangitis using phage display. Hepatology 34: 478-486. *

• Invernizzi P, Invernizzi P, Gershwin ME 2008 The genetic basis of primary biliary cirrhosis: premises, not promises. Gastroenterology Sep 3 [Epub ahead of print]. *

• Invernizzi P, Selmi C, Zuin M, Podda M 2005 Lack of serum antibodies to membrane bound carbonic anhydrase IV in patients with primary biliary cirrhosis. Gut 54: 1665. *

• Ishibashi H 2001 Are primary biliary cirrhosis and autoimmune cholangitis reflective of the pendulum of a clock and therefore represent a 'phase' of the same disease? J. Gastroenterol. Hepatol. 16: 121-123.

• Jiang XH, Zhong RQ, Yu SQ, Hu Y, Li WW, Kong XT 2003 Construction and expression of a humanized M2 autoantigen trimer and its application in the diagnosis of primary biliary cirrhosis. World J. Gastroenterol. 9: 1352-1355. *

• Jones DE, Palmer JM, Kirby JA, De Cruz DJ, McCaughan GW, Sedgwick JD, Yeaman SJ, Burt AD, Bassendine MF 2000 Experimental autoimmune cholangitis: a mouse model of immune-mediated cholangiopathy. Liver 20: 351-356.

• Jones DE, Palmer JM, Yeaman SJ, Kirby JA, Bassendine MF 1999 Breakdown of tolerance to pyruvate dehydrogenase complex in experimental autoimmune cholangitis: a mouse model of primary biliary cirrhosis. Hepatology 30: 65-70. *

• Kadokawa Y, Omagari K, Ohba K, Masuda J, Hazama H, Kinoshita H, Ohnita K, Mizuta Y, Tanioka H, Imanishi T, Kohno S 2005 Does the diagnosis of primary biliary cirrhosis or autoimmune cholangitis depend on the 'phase' of the disease? Liver Int. 25: 317-324. *

• Kanda K, Onji M, Ohta Y 1993 Spontaneous occurrence of autoimmune cholangitis in senescent mice. J. Gastroenterol. Hepatol. 8: 7-14.

• Kaserer K, Exner M, Mosberger I, Penner E, Wrba F 1998 Characterization of the inflammatory infiltrate in autoimmune cholangitis. A morphological and immunhistochemical study. Virchows Arch. 432: 217-222. *

• Katsanos KH, Kitsanou M, Christodoulou DK, Tsianos EV 2002 High CA 19-9 levels in benign biliary tract diseases. Report of four cases and review of the literature. Eur. J. Intern. Med. 13: 132-135.

• Kim JH, Kim BH, Kim YW, Park JC, Jung YH, Lee BO, Han YS, Dong SH, Kim HJ, Chang YW, Lee JI, Chang R 2004 Autoimmune cholangitis in a patient with thymoma. J. Gastroenterol. Hepatol. 19: 1324-1327. *

• Kim WR, Ludwig J, Lindor KD 2000 Variant forms of cholestatic diseases involving small bile ducts in adults. Am. J. Gastroenterol. 95: 1130-1138. *

• Kim WR, Poterucha JJ, Jorgensen RA, Batts KP, Homburger HA, Dickson ER, Krom RA, Wiesner RH, Lindor KD 1997 Does antimitochondrial antibody status affect response to treatment in patients with primary biliary cirrhosis? Outcomes of ursodeoxycholic acid therapy and liver transplantation. Hepatology 26: 22-26. *

• Kinoshita H, Omagari K, Whittingham S, Kato Y, Ishibashi H, Sugi K, Yano M, Kohno S, Nakanuma Y, Penner E, Wesierska-Gadek J, Reynoso-Paz S, Gershwin ME, Anderson J, Jois JA, Mackay IR 1999 Autoimmune cholangitis and primary biliary cirrhosis - an autoimmune enigma. Liver 19: 122-128.

• Kobashi H, Yamamoto K, Yoshioka T, Tomita M, Tsuji T 1994 Nonsuppurative cholangitis is induced in neonatally thymectomized mice: a possible animal model for primary biliary cirrhosis. Hepatology 19: 1424-1430.

• Koulentaki M, Koutroubakis IE, Petinaki E, Tzardi M, Oekonomaki H, Mouzas I, Kouroumalis EA 1999 Ulcerative colitis associated with primary biliary cirrhosis. Dig. Dis. Sci. 44: 1953-1956. *

• Koulentaki M, Moscandrea J, Dimoulios P, Chatzicostas C, Kouroumalis EA 2004 Survival of anti-mitochondrial antibody-positive and -negative primary biliary cirrhosis patients on ursodeoxycholic acid treatment. Dig. Dis. Sci. 49: 1190-1195. *

• Kuroiwa T, Suda T, Takahashi T, Hirono H, Natsui M, Motoyama H, Nomoto M, Aoyagi Y 2002 Bile duct involvement in a case of autoimmune pancreatitis successfully treated with an oral steroid. Dig. Dis. Sci. 47: 1810-1816. *

• Lacerda MA, Ludwig J, Dickson ER, Jorgensen RA, Lindor KD 1995 Antimitochondrial antibody-negative primary biliary cirrhosis. Am. J. Gastroenterol. 90: 247-249.

• Lazaridis KN, Lindor KD 1999 Primary biliary cirrhosis. Curr. Treat. Options Gastroenterol. 2: 473-480.

• Lee J, Chang KH, Park CS, Lee CH, Song CH, Park YN, Park C, Lee SK 1998 A case of autoimmune cholangitis associated with Sjogren's syndrome and arthropathy. J. Korean Med. Sci. 13: 85-88.

• Lee SO 2008 Physiologic and pathologic experimental models for studying cholangiocytes. Korean J. Hepatol. 14: 139-149.

• Leung PS, Park O, Tsuneyama K, Kurth MJ, Lam KS, Ansari AA, Coppel RL, Gershwin ME 2007 Induction of primary biliary cirrhosis in guinea pigs following chemical xenobiotic immunization. J. Immunol. 179: 2651-2657. *

• Leuschner U 2006 Autoimmune hepatitis/PSC-overlap syndrome. Falk Workshop "Primary Sclerosing Cholangitis: Complications and Consequences", Moscow (Russia), June 11, 2006, p. 10-11. *

• Li CP, Tong MJ, Hwang SJ, Luo JC, Co RL, Tsay SH, Chang FY, Lee SD 2000 Autoimmune cholangitis with features of autoimmune hepatitis: successful treatment with immunosuppressive agents and ursodeoxycholic acid. J. Gastroenterol. Hepatol. 15: 95-98. *

• Lindor KD 2004 Dose effect relationship of UDCA for PBC and PSC. Falk Symposium 141. XVIII International Bile Acid Meeting: Bile Acid Biology and its Therapeutic Implications. Stockholm (Sweden). p. 69. June 18-19. *

• Lozano A, Vildosola H, Takano J, Vargas G, Uribe R, Moreno C 2000 Clinical and immunological profile in 22 patients with primary biliary cirrhosis. Rev. Gastroenterol. Peru. 20: 14-24.

• Ludwig J 2000 The pathology of primary biliary cirrhosis and autoimmune cholangitis. Best Pract. Res. Clin. Gastroenterol. 14: 601-613.

• Ludwig J 1998 Idiopathic adulthood ductopenia: an update. Mayo Clin. Proc. 73: 285-291.

• Maggiore G, Sciveres M 2005 Autoimmune hepatitis: a childhood disease. Current Pediatric Reviews 1: 73-90. *

• Manns MP 1997 Recent developments in autoimmune liver diseases. J. Gastroenterol. Hepatol. 12: S256-S271.

• Marignani M, Angeletti S, Mari T, D'Alessandro P, Palumbo P, Dato A, Zullo A 2002 Coeliac disease and autoimmune cholangitis: a case report. Dig. Liver Dis. 34: 862-865.

• Marinho R, Graca H, Ramalho F, Costa A, Batista A, De Moura MC 2001 Autoimmune cholangiopathy. Acta Med. Port. 14: 361-366.

• Marinho R, Graca H, Ramalho F, Costa A, Batista A, de Moura MC 1999 Autoimmune cholangitis: case report. Hepatogastroenterology 46: 1949-1952.

• Masanaga T, Watanabe Y, Van de Water J, Leung PS, Nakanishi T, Kajiyama G, Ruebner BH, Coppel RL, Gershwin ME 1998 Induction and persistence of immune-mediated cholangiohepatitis in neonatally thymectomized mice. Clin. Immunol. Immunopathol. 89: 141-149. *

• Masuda J, Omagari K, Matsuo I, Kinoshita H, Sakimura K, Hazama H, Ohba K, Isomoto H, Murase K, Murata I, Kohno S 2001 Changes in titers of antimitochondrial and antinuclear antibodies during the course of primary biliary cirrhosis. J. Gastroenterol. Hepatol. 16: 239-243. *

• Mendes F, Lindor KD 2008 Antimitochondrial antibody-negative primary biliary cirrhosis. Gastroenterol. Clin. North Am. 37: 479-484.

• Michieletti P, Wanless IR, Katz A, Scheuer PJ, Yeaman SJ, Bassendine MF, Palmer JM, Heathcote EJ 1994 Antimitochondrial antibody negative primary biliary cirrhosis: a distinct syndrome of autoimmune cholangitis. Gut 35: 260-265. *

• Mitry E, Algayres JP, Bili H, Coutant G, Gros P, Nizou JY, Castagne C, Vergeau B, Daly JP 1998 Autoimmune cholangitis successfully treated with corticotherapy. One case. Gastroenterol. Clin. Biol. 22: 94-97.

• Miyakawa H, Kitazawa E, Fujikawa H, Kikuchi K, Abe K, Kawaguchi N, Kako M 2000 Analysis of two major anti-M2 antibodies (anti-PDC-E2/anti-BCOADC-E2) in primary biliary cirrhosis: relationship to titers of immunofluorescent anti-mitochondrial antibody. Hepatol. Res. 18: 1-9.

• Muratori L, Muratori P, Zauli D, Grassi A, Pappas G, Rodrigo L, Cassani F, Lenzi M, Bianchi FB 2001 Antilactoferrin antibodies in autoimmune liver disease. Clin. Exp. Immunol. 124: 470-473. *

• Nakajima M, Shimizu H, Miyazaki A, Watanabe S, Kitami N, Sato N 1999 Detection of IgA, IgM, and IgG subclasses of anti-M2 antibody by immunoblotting in autoimmune cholangitis: is autoimmune cholangitis an early stage of primary biliary cirrhosis? J. Gastroenterol. 34: 607-612. *

• No authors listed 2005 Diagnosis of primary biliary cirrhosis and autoimmune cholangitis. Nat. Clin. Pract. Gastroenterol. Hepatol. 2: 251. *

• O'Donohue J, Wong T, Portmann B, Williams R 2002 Immunohistochemical differences in the portal tract and acinar infiltrates between primary biliary cirrhosis and autoimmune cholangitis. Eur. J. Gastroenterol. Hepatol. 14: 1143-1150.

• Ohana M, Okazaki K, Hajiro K, Uchida K 1998 Antilactoferrin antibodies in autoimmune liver diseases. Am. J. Gastroenterol. 93: 1334-1339. *

• Okada C, Akbar SM, Horiike N, Onji M 2005 Early development of primary biliary cirrhosis in female C57BL/6 mice because of poly I:C administration. Liver Int. 25: 595-603. *

• Omagari K, Ikuno N, Matsuo I, Shirono K, Hara K, Feeney SJ, Whittingham S, Mackay IR 1996 Autoimmune cholangitis syndrome with a bias towards primary biliary cirrhosis. Pathology 28: 255-258.

• Poupon R, Chazouilleres O, Poupon RE 2000 Chronic cholestatic diseases. J. Hepatol. 32: S129-S140.

• Premoli A, Morello E, Bo S, Durazzo M 2007 Diagnostic and therapeutic questions in overlap syndromes of autoimmune hepatitis. Minerva Gastroenterol. Dietol. 53: 79-82.

• Primo J, Miralles A, Ferrando J, Albert A, Julve R, Gomez A, Garcia L 1999 Atypical primary biliary cirrhosis or autoimmune cholangitis? Gastroenterol. Hepatol. 22: 505-509.

• Romero Gomez M, Wichmann I, Otero Fernandez MA, Suarez Garcia E, Grande L, Nunez J, Nevado Santos M, Castro Fernandez M 1999 Anti-Sp100 and anti-Gp210 in the diagnosis of primary biliary cirrhosis in patients with autoimmune cholangitis. Gastroenterol. Hepatol. 22: 11-13.

• Romero-Gomez M, Wichmann I, Crespo J, Pares A, Rodrigo L, Alvarez A, Diago M, Pons-Romero F, Sanchez-Munoz D, Aguilar-Reina J, Andrade RJ, Salmeron J, Sanchez-Pobre P, Rebollo JM, Martin-Vivaldi R, Castellano-Megias V, Nunez-Roldan A, Bruguera M 2004 Serum immunological profile in patients with chronic autoimmune cholestasis. Am. J. Gastroenterol. 99: 2150-2157. *

• Rust C, Beuers U 2008 Overlap syndromes among autoimmune liver diseases. World J. Gastroenterol. 14: 3368-3373. *

• Sakauchi F, Mori M, Zeniya M, Toda G 2006 Antimitochondrial antibody negative primary biliary cirrhosis in Japan: utilization of clinical data when patients applied to receive public financial aid. J. Epidemiol. 16: 30-34. *

• Salo J, Caballeria L, Bruguera M, Pares A, Rodes J 1997 Autoimmune cholangitis or primary biliary cirrhosis without antimitochondrial antibodies? Gastroenterol. Hepatol. 20: 5-10.

• Samonakis DN, Chatzicostas C, Vardas E, Matrella E, Hatzidakis A, Kouroumalis EA 2006 Autoimmune cholangitis in twin sisters. Acta Gastroenterol. Belg. 69: 340-341.

• Sanchez-Munoz D, Castellano-Megias VM, Romero-Gomez M 2007 Expression of bcl-2 in ductular proliferation is related to periportal hepatic stellate cell activation and fibrosis progression in patients with autoimmune cholestasis. Dig. Liver Dis. 39: 262-266.

• Sanchez-Pobre P, Castellano G, Colina F, Dominguez P, Rodriguez S, Canga F, Herruzo JA 1996 Antimitochondrial antibody-negative chronic nonsuppurative destructive cholangitis. Atypical primary biliary cirrhosis or autoimmune cholangitis? J. Clin. Gastroenterol. 23: 191-198.

• Sanchez-Pobre P, Castellano G, Colina F, Dominguez P, Rodriguez S, Canga F, Solis-Herruzo JA 1997 Autoimmune cholangitis. Gastroenterol. Hepatol. 20: 474.

• Sanchez-Pobre P, Gonzalez C, Paz E, Colina F, Castellano G, Munoz-Yague T, Rodriguez S, Yela C, Alvarez V, Solis-Herruzo J 2002 Chronic hepatitis C and autoimmune cholangitis: a case study and literature review. Dig. Dis. Sci. 47: 1224-1229. *

• Sanchez-Pobre P, Solis-Herruzo J 2003 Autoimmune cholangitis, nosological location. Rev. Esp. Enferm. Dig. 95: 791-794.

• Sasaki M, Allina J, Odin JA, Thung SN, Coppel R, Nakanuma Y, Gershwin ME 2002 Autoimmune cholangitis in the SJL/J mouse is antigen non-specific. Dev. Immunol. 9: 103-111. *

• Schedel J, Mayer S, Woenckhaus M, Kiss E, Scholmerich J, Rogler G 2004 Autoimmune cholangitis with vasculitic ulcers, rheumatoid arthritis and IgA glomerulonephritis. Dtsch. Med. Wochenschr. 129: 2409-2412.

• Sciveres M, Caprai S, Palla G, Ughi C, Maggiore G 2004 Effectiveness and safety of ciclosporin as therapy for autoimmune diseases of the liver in children and adolescents. Aliment. Pharmacol. Ther. 19: 209-217. *

• Sedlack RE, Smyrk TC, Czaja AJ, Talwalkar JA 2002 Celiac disease-associated autoimmune cholangitis. Am. J. Gastroenterol. 97: 3196-3198. *

• Sherlock S 1998 Overview of chronic cholestatic conditions in adults: terminology and definitions. Clin. Liver Dis. 2: 217-233, vii.

• Sherlock S 1998 Ludwig Symposium on biliary disorders. Autoimmune cholangitis: a unique entity? Mayo Clin. Proc. 73: 184-190.

• Sherlock S 2000 Primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune cholangitis. Clin. Liver Dis. 4: 97-113.

• Singson RC, Fraiman M, Geller SA 1999 Hepatocellular carcinoma with fibrolamellar pattern in a patient with autoimmune cholangitis. Mt. Sinai J. Med. 66: 109-112. *

• Taylor SL, Dean PJ, Riely CA 1994 Primary autoimmune cholangitis. An alternative to antimitochondrial antibody-negative primary biliary cirrhosis. Am. J. Surg. Pathol. 18: 91-99.

• Terjung B, Spengler U 2005 Role of auto-antibodies for the diagnosis of chronic cholestatic liver diseases. Clin. Rev. Allergy Immunol. 28: 115-133. *

• Terracciano LM, Patzina RA, Lehmann FS, Tornillo L, Cathomas G, Mhawech P, Vecchione R, Bianchi L 2000 A spectrum of histopathologic findings in autoimmune liver disease. Am. J. Clin. Pathol. 114: 705-711.

• Thimme R, Opitz OG, Blum HE, Kreisel W 2004 Cholestatic liver diseases. Ther. Umsch. 61: 521-527.

• Ueno Y, Ishii M, Takahashi S, Igarashi T, Toyota T, LaRusso NF 1998 Different susceptibility of mice to immune-mediated cholangitis induced by immunization with carbonic anhydrase II. Lab. Invest. 78: 629-637.

• Veijola L, Nilsson I, Halme L, Al-Soud WA, Makinen J, Ljungh A, Rautelin H 2007 Detection of Helicobacter species in chronic liver disease and chronic inflammatory bowel disease. Ann. Med. 39: 554-560.

• Volta U, Rodrigo L, Granito A, Petrolini N, Muratori P, Muratori L, Linares A, Veronesi L, Fuentes D, Zauli D, Bianchi FB 2002 Celiac disease in autoimmune cholestatic liver disorders. Am. J. Gastroenterol. 97: 2609-2613. *

• Wakabayashi K, Lian ZX, Leung PS, Moritoki Y, Tsuneyama K, Kurth MJ, Lam KS, Yoshida K, Yang GX, Hibi T, Ansari AA, Ridgway WM, Coppel RL, Mackay IR, Gershwin ME 2008 Loss of tolerance in C57BL/6 mice to the autoantigen E2 subunit of pyruvate dehydrogenase by a xenobiotic with ensuing biliary ductular disease. Hepatology 48: 531-540.

• Washington K 2002 Autoimmune cholangitis: not just AMA-negative primary biliary cirrhosis. Adv. Anat. Pathol. 9: 244-250.

• Yamamoto K, Terada R, Okamoto R, Hiasa Y, Abe M, Onji M, Tsuji T 2003 A scoring system for primary biliary cirrhosis and its application for variant forms of autoimmune liver disease. J. Gastroenterol. 38: 52-59. *

• Yang GX, Lian ZX, Chuang YH, Moritoki Y, Lan RY, Wakabayashi K, Ansari AA, Flavell RA, Ridgway WM, Coppel RL, Tsuneyama K, Mackay IR, Gershwin ME 2008 Adoptive transfer of CD8(+) T cells from transforming growth factor beta receptor type II (dominant negative form) induces autoimmune cholangitis in mice. Hepatology 47: 1974-1982.

• Yeaman SJ, Kirby JA, Jones DE 2000 Autoreactive responses to pyruvate dehydrogenase complex in the pathogenesis of primary biliary cirrhosis. Immunol. Rev. 174: 238-249. *

• Yotsuyanagi H, Koike K, Meng G, Yasuda K, Ogata I, Kimura S, Ohkubo A 1998 Acute exacerbation of autoimmune liver disease associated with hantaviral infection. Scand. J. Infect. Dis. 30: 81-83.

Number of references = 124

www psc-literature.org